These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3893868

  • 1. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A, Sau F, Mercuro G, Seguro C, Lai O.
    Clin Ter; 1985 May 31; 113(4):301-6. PubMed ID: 3893868
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F, Chiarini C, Degli Esposti E, Santoro A, Sturani A, Zuccalà A, Zucchelli P.
    Clin Ter; 1983 Aug 15; 106(3):209-12. PubMed ID: 6627892
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS, Fand RS.
    Ir Med J; 1979 Dec 15; 72(12):522-9. PubMed ID: 44273
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
    Am J Cardiol; 1983 Dec 01; 52(10):1230-7. PubMed ID: 6359851
    [Abstract] [Full Text] [Related]

  • 8. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
    Del Re ML, Ricci A, Abate G.
    Clin Ter; 1986 Mar 15; 116(5):385-90. PubMed ID: 2871962
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind study of Inderex in the treatment of essential hypertension.
    Crowe PF, Finnegan OC, Russell CJ, Varma MP.
    Br J Clin Pract; 1987 Oct 15; 41(10):967-70. PubMed ID: 3333146
    [No Abstract] [Full Text] [Related]

  • 11. [Our experience on the clinical use of nadolol].
    Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G.
    Minerva Cardioangiol; 1985 Oct 15; 33(10):629-34. PubMed ID: 2867492
    [No Abstract] [Full Text] [Related]

  • 12. Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.
    Wilcox RG.
    Postgrad Med J; 1977 Oct 15; 53 Suppl 3():128-33. PubMed ID: 337267
    [No Abstract] [Full Text] [Related]

  • 13. Timolol and bendroflumethiazide in the treatment of hypertension.
    Karatzas NB, Papazachos G, Clouva P, Tsaknakis T.
    J Int Med Res; 1979 Oct 15; 7(3):215-20. PubMed ID: 378730
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
    De Cesaris R, Ranieri G, Chiarappa R, Balestrazzi M, Antoncecchi E.
    Clin Ter; 1986 Mar 31; 116(6):465-71. PubMed ID: 3522061
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Controlled evaluation of bendroflumethiazide in the treatment of essential hypertension.
    Spitzer TQ, Harris BA.
    Curr Ther Res Clin Exp; 1975 Jan 31; 17(1):75-9. PubMed ID: 806431
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.